Dare Bioscience, Inc.
DARE· Nasdaq
DAREDare Bioscience, Inc.
Filed May 27, 2014 · 10-Q · 57 days after period end · 0001193125-14-212644
| Metric | Q1 2014 | Q1 2013 |
|---|---|---|
| Revenue | $47.00K | — |
| Net Income | -$2.91M | -$5.57M |
| EPS Diluted | -$3.70 | -$9.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
ended Mar 31, 2014 · filed May 27, 2014 · 57 d after period end
